SCHEMBL25528576

SCHEMBL25528576

CC(=O)COc1cc(Cl)c(Cc2ccc(O)c(-c3ccco3)c2)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 8/20 0.53
THRB P10828 8/20 0.53
KMT2A Q03164 4/20 0.39
PTPN1 P18031 1/20 0.39
TP53 P04637 3/20 0.37
MAPT P10636 4/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
KDM4E B2RXH2 2/20 0.34
NPSR1 Q6W5P4 2/20 0.34
RECQL P46063 1/20 0.34
POLB P06746 1/20 0.34
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
HSD17B10 Q99714 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23003660 0.91 THRB (0.62) THRATHRBKMT2APTPN1MEN1
SCHEMBL25528706 0.84 THRA (0.57) THRATHRBALDH1A1HPGDUSP2
SCHEMBL25528584 0.82 THRB (0.49) THRATHRBKMT2ATP53MAPT
SCHEMBL25528523 0.82 THRA (0.51) THRATHRBMAPTHTTPOLB
SCHEMBL25528577 0.82 THRA (0.51) THRATHRBALDH1A1HPGDUSP2
SCHEMBL25528533 0.81 THRA (0.51) THRATHRBKMT2AALDH1A1KDM4E
SCHEMBL25528562 0.81 THRA (0.52) THRATHRB
SCHEMBL25528569 0.79 THRB (0.50) THRATHRBKMT2ATP53MAPT
SCHEMBL25528539 0.79 THRA (0.50) THRATHRBMAPT
SCHEMBL25528534 0.79 THRA (0.50) THRATHRBALDH1A1HPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667606-B2 Thyromimetics AUTOBAHN THERAPEUTICS, INC. (US) 2023-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667606-B2 Thyromimetics TPO, TSHR, TTR THRA 4/4885THRB 9/4885KMT2A 4284/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.